- Home
- PAYO vs ASTH Comparison
PAYO vs ASTH Comparison
Compare PAYO & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYO | ASTH |
|---|---|---|
| Founded | 2005 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Professional Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PAYO | ASTH |
|---|---|---|
| Price | $5.94 | $23.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $9.79 | ★ $41.33 |
| AVG Volume (30 Days) | ★ 2.6M | 510.1K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.18 | ★ 0.20 |
| Revenue | $1,039,820,000.00 | ★ $2,896,452,000.00 |
| Revenue This Year | $11.18 | $58.37 |
| Revenue Next Year | $7.45 | $25.48 |
| P/E Ratio | ★ $32.66 | $120.29 |
| Revenue Growth | 10.58 | ★ 68.17 |
| 52 Week Low | $4.92 | $20.12 |
| 52 Week High | $11.19 | $39.97 |
Technical Indicators
Market Signals| Indicator | PAYO | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 59.83 | 49.51 |
| Support Level | $5.61 | $20.64 |
| Resistance Level | $5.98 | $23.23 |
| Average True Range (ATR) | 0.16 | 0.95 |
| MACD | 0.05 | 0.35 |
| Stochastic Oscillator | 93.52 | 94.93 |
Price Performance
Historical ComparisonAbout PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.